Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -13.38%.

  • Lifecore Biomedical's EBITDA Margin rose 894.00% to 14.62% in Q2 2025 from the same period last year, while for May 2025 it was -13.38%, marking a year-over-year decrease of 2995.00%. This contributed to the annual value of -13.38% for FY2025, which is 649.00% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's EBITDA Margin is -13.38%, which was down 94.07% from -6.90% recorded in FY2024.
  • Lifecore Biomedical's EBITDA Margin's 5-year high stood at -6.90% during FY2024, with a 5-year trough of -21.11% in FY2023.
  • In the last 3 years, Lifecore Biomedical's EBITDA Margin had a median value of -13.38% in 2025 and averaged -13.79%.
  • Per our database at Business Quant, Lifecore Biomedical's EBITDA Margin slumped by 1,051bps in 2023 and then spiked by 1,421bps in 2024.
  • Lifecore Biomedical's EBITDA Margin (Yearly) stood at -8.75% in 2021, then tumbled by 185bps to -10.60% in 2022, then crashed by 1,051bps to -21.11% in 2023, then skyrocketed by 1,421bps to -6.90% in 2024, then crashed by 649bps to -13.38% in 2025.